|
|
Sold Out
Book Categories |
| List of Contributors | ||
| Introduction | ||
| Pt. 1 | Mechanisms of progression and regression | |
| 1 | Role of lipoproteins in progression of coronary arteriosclerosis | |
| 2 | Pathophysiological basis for lipid intervention trials | |
| Pt. 2 | Methodological aspects of angiographic trials | |
| 3 | The use of metabolic measurements in angiographic regression trials | |
| 4 | Quality control in quantitative coronary arteriography | |
| 5 | Is there a place for visual assessment? | |
| 6 | Angiographic endpoints in progression trials | |
| Pt. 3 | Angiographic lipid lowering clinical trials | |
| 7 | The Cholesterol Lowering Atherosclerosis Study (CLAS) | |
| 8 | Clinical efficacy and safety of pravastatin treatment in symptomatic patients - the REGRESS trial | |
| 9 | Familial Atherosclerosis Treatment Study | |
| 10 | Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC 1): a summary | |
| 11 | The Multicenter Anti-Atheroma Study (MAAS) | |
| 12 | Lessons from the Monitored Atherosclerosis Regression Study (MARS) and beyond: atherosclerosis progression/regression responses to therapy depend on lesion size and composition | |
| 13 | The St Thomas Atherosclerosis Regression Study and an appraisal of its potential limitations | |
| 14 | Effects of the lipid intervention in the Stanford Coronary Risk Intervention Project | |
| 15 | Canadian coronary atherosclerosis study on the effect of lovastatin on the progression of coronary artery disease (CCAIT): why are results different? | |
| 16 | Impact upon angiographic disease progression following step drug therapy in normolipidaemic patients: results of the Harvard Atherosclerosis Reversibility Project (HARP) | |
| 17 | Effect of aggressive versus conventional lipid-lowering treatment on coronary and peripheral atherosclerosis: design and baseline characteristics of the LDL-Apheresis Atherosclerosis Regression Study (LAARS) | |
| 18 | The NHLBI Post-Coronary Artery Bypass Graft Clinical Trial (Post-CABG): angiographic outcomes | |
| Epilogue | ||
| Index |
| Price | Condition | Delivery | Seller | Action |
| $99.99 | Digital |
| WonderClub |
Login|Complaints|Blog|Games|Digital Media|Souls|Obituary|Contact Us|FAQ
CAN'T FIND WHAT YOU'RE LOOKING FOR? CLICK HERE!!! X
You must be logged in to add to WishlistX
This item is in your Wish List
X
This item is in your Collection
Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis
X
This Item is in Your Inventory
Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis
X
You must be logged in to review the productsX
X
X
Add Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis, A unique overview of all major angiographic lipid intervention trials, presented by their principal investigators. Basic mechanisms and methodological aspects, including biochemical as well as angiographic aspects, are discussed by experts in these fields, Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis to the inventory that you are selling on WonderClubX
X
Add Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis, A unique overview of all major angiographic lipid intervention trials, presented by their principal investigators. Basic mechanisms and methodological aspects, including biochemical as well as angiographic aspects, are discussed by experts in these fields, Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis to your collection on WonderClub |